# Asimov > Asimov is a synthetic biology company building an integrated platform for the intelligent design of living systems. Its Edge Systems (CHO, LV, AAV, and RNA) combine engineered mammalian host cells, a library of more than 1,000 validated genetic parts, and cloud-based genetic design software so biopharma partners can design and manufacture advanced therapeutics. No public developer API is currently published. ## Products - [CHO Edge System](https://www.asimov.com/): Host-cell + genetic-design system for biologics production. - [LV Edge System](https://www.asimov.com/): Lentiviral system for cell therapies. - [AAV Edge System](https://www.asimov.com/): Adeno-associated virus system for gene therapies. - [RNA Edge System](https://www.asimov.com/): System for RNA therapeutics candidate development. ## Company - [Website](https://www.asimov.com/): Company home. - [About](https://www.asimov.com/about): Company overview and mission. - [Contact](https://www.asimov.com/contact): Get in touch / partnership inquiries. - [Careers](https://jobs.ashbyhq.com/asimov): Open roles. ## Docs - [Engineering Blog](https://asimovbio.substack.com/): Asimov engineering and research writing. - [Press](https://press.asimov.com): News and press releases. - [GitHub](https://github.com/asimovbio): Asimov open source organization. - [Terms of Service](https://www.asimov.com/terms-of-service) - [Privacy Policy](https://www.asimov.com/privacy-policy)